Alcon Management
Management criteria checks 4/4
Alcon's CEO is David Endicott, appointed in Jul 2018, has a tenure of 6.33 years. total yearly compensation is $12.33M, comprised of 10.7% salary and 89.3% bonuses, including company stock and options. directly owns 0.047% of the company’s shares, worth $20.69M. The average tenure of the management team and the board of directors is 5 years and 5.8 years respectively.
Key information
David Endicott
Chief executive officer
US$12.3m
Total compensation
| CEO salary percentage | 10.7% |
| CEO tenure | 6.3yrs |
| CEO ownership | 0.05% |
| Management average tenure | 5yrs |
| Board average tenure | 5.8yrs |
Recent management updates
Recent updates
Alcon Q2: Positive News From Unity VCS/CS And AR-15512
Sep 04Alcon: Trading At An Undeserved Premium Valuation
Aug 01Alcon Q1: Robust Product Pipeline Drives Future Growth (Rating Upgrade)
May 14Alcon: Buy An Eyecare Leader With $2 Billion In Quarterly Sales
Oct 10Alcon: Lackluster Growth Given Its Valuation
Jul 26Alcon: The Steady Force Of 'Boring'
Jun 27Alcon reached $199M settlement with J&J Surgical Vision
Feb 13Alcon: Case Of Growth Destructive To Value, Reiterate Hold At 24x Earnings
Feb 01Alcon a buy at Mizuho on 'eyecare dominance'
Dec 22Alcon Q3 2022 Earnings Preview
Nov 14Alcon: Looking To Break Downtrend Before Entry
Sep 04Alcon downgraded to hold at Societe Generale on macro headwinds
Aug 11Alcon: Revisiting The Investment Thesis
Jun 03The Recent Pullback Makes Alcon More Attractive
Mar 18Alcon: Good Quarterly Results, But It Is Still Expensive
Dec 22Looking At Alcon Through A Different Lens
Sep 11Alcon Inc. 2021 Q1 - Results - Earnings Call Presentation
May 06Alcon to acquire U.S. commercialization rights to ophthalmic eye drops Simbrinza from Novartis
Apr 28Alcon: Global Leader In An Attractive End-Market
Dec 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$1b |
| Jun 30 2024 | n/a | n/a | US$1b |
| Mar 31 2024 | n/a | n/a | US$1b |
| Dec 31 2023 | US$12m | US$1m | US$974m |
| Sep 30 2023 | n/a | n/a | US$450m |
| Jun 30 2023 | n/a | n/a | US$362m |
| Mar 31 2023 | n/a | n/a | US$341m |
| Dec 31 2022 | US$10m | US$1m | US$335m |
| Sep 30 2022 | n/a | n/a | US$571m |
| Jun 30 2022 | n/a | n/a | US$457m |
| Mar 31 2022 | n/a | n/a | US$460m |
| Dec 31 2021 | US$11m | US$1m | US$376m |
| Sep 30 2021 | n/a | n/a | US$332m |
| Jun 30 2021 | n/a | n/a | US$183m |
| Mar 31 2021 | n/a | n/a | -US$390m |
| Dec 31 2020 | US$8m | US$1m | -US$531m |
| Sep 30 2020 | n/a | n/a | -US$717m |
| Jun 30 2020 | n/a | n/a | -US$636m |
| Mar 31 2020 | n/a | n/a | -US$604m |
| Dec 31 2019 | US$7m | US$1m | -US$656m |
Compensation vs Market: David's total compensation ($USD12.33M) is about average for companies of similar size in the US market ($USD12.64M).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
CEO
David Endicott (59 yo)
6.3yrs
Tenure
US$12,325,391
Compensation
Mr. David J. Endicott is President and Chief Executive Officer at Aerie Pharmaceuticals, Inc. since November 21, 2022. He had been the Chief Executive Officer of Alcon, Inc. since July 1, 2018. He is the C...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 5.8yrs | US$1.17m | 0.011% $ 5.0m | |
| CEO & Director | 6.3yrs | US$12.33m | 0.047% $ 20.7m | |
| Executive Director | no data | US$284.68k | 0.0012% $ 514.1k | |
| Senior VP & CFO | 5.6yrs | no data | 0.020% $ 8.6m | |
| Senior VP & COO | less than a year | no data | 0.0081% $ 3.6m | |
| Chief Accounting Officer | no data | no data | no data | |
| SVP of Global Research & Development and Chief Scientific Officer | 2.4yrs | no data | no data | |
| Senior VP and Chief Information & Transformation Officer | no data | no data | no data | |
| Senior VP | no data | no data | no data | |
| Senior VP | 4.3yrs | no data | no data | |
| SVP of Corporate Strategy | no data | no data | 0.0040% $ 1.7m | |
| Senior VP & President of Americas | 9.3yrs | no data | 0.0043% $ 1.9m |
5.0yrs
Average Tenure
57yo
Average Age
Experienced Management: ALC's management team is considered experienced (5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 5.8yrs | US$1.17m | 0.011% $ 5.0m | |
| CEO & Director | 5.8yrs | US$12.33m | 0.047% $ 20.7m | |
| Executive Director | 5.8yrs | US$284.68k | 0.0012% $ 514.1k | |
| Independent Director | 5.8yrs | US$325.52k | 0.0052% $ 2.3m | |
| Independent Vice Chair | 5.8yrs | US$361.69k | 0.0031% $ 1.3m | |
| Independent Director | 5.8yrs | US$352.98k | 0.0041% $ 1.8m | |
| Independent Director | 5.8yrs | US$236.83k | 0.0049% $ 2.2m | |
| Independent Director | 5.8yrs | US$333.87k | 0.0031% $ 1.3m | |
| Independent Director | 5.8yrs | US$296.31k | 0.0019% $ 856.9k | |
| Independent Director | 5.8yrs | US$293.86k | 0.0021% $ 931.6k | |
| Independent Director | 2.6yrs | US$256.66k | 0.00056% $ 246.1k |
5.8yrs
Average Tenure
63yo
Average Age
Experienced Board: ALC's board of directors are considered experienced (5.8 years average tenure).